GlassScriptPhysician profile
Nicole Wiggins
NPI 1013582899
$1,261.95
in general payments reported to CMS, 2019-2025
20 companies · $37.86 in 2025
The $37.86 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $141 · 2022: $593 · 2023: $385 · 2024: $105 · 2025: $37.86.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $528.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $528.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $206.64 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $136.87 | 2021-2023 | Lifevest |
| Jazz Pharmaceuticals INC. | $132.90 | 2021-2022 | |
| Avadel Cns Pharmaceuticals, LLC | $117.85 | 2023 | Lumryz |
| Merck Sharp & Dohme LLC | $112.53 | 2021-2023 | Verquvo, Belsomra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $92.67 | 2022-2024 | Ofev |
| Novo Nordisk INC | $76.79 | 2022-2023 | Ozempic |
| Takeda Pharmaceuticals U.S.A., INC. | $54.55 | 2023 | Glassia |
| Astrazeneca Pharmaceuticals LP | $47.27 | 2021-2023 | Bevespi Aerosphere |
| Amgen INC. | $39.60 | 2021-2022 | |
| Galderma Laboratories, L.P. | $37.86 | 2025 | |
| Irhythm Technologies, INC. | $34.92 | 2022-2023 | Zio Xt Patch |
| Glaxosmithkline, LLC. | $32.53 | 2024 | Trelegy Ellipta |
| Inogen, INC. | $28.36 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $25.04 | 2023 | Dupixent |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $22.49 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $18.58 | 2023 | Uptravi, Opsumit |
| Genzyme Corporation | $15.19 | 2022 | |
| Currax Pharmaceuticals LLC | $14.67 | 2022 | |
| Baxter Healthcare | $14.64 | 2023 | Hillrom - Life 2000 Ventilation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Wiggins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.